These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8607524)

  • 1. P53 levels in the evaluation of malignant/benign pancreaticobiliary disease: hope or hype?
    Gessner CE; Baillie J
    Am J Gastroenterol; 1996 Feb; 91(2):401-2. PubMed ID: 8607524
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urine diacetylspermine as a novel tumor marker for pancreatobiliary carcinomas].
    Yamaguchi K; Nagano M; Torada N; Hamasaki N; Kawakita M; Tanaka M
    Rinsho Byori; 2004 Apr; 52(4):336-9. PubMed ID: 15164602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve.
    Kim HJ; Kim MH; Myung SJ; Lim BC; Park ET; Yoo KS; Seo DW; Lee SK; Min YI
    Am J Gastroenterol; 1999 Jul; 94(7):1941-6. PubMed ID: 10406263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of stent cytology for the diagnosis of pancreaticobiliary neoplasms.
    Devereaux BM; Fogel EL; Bucksot L; Shelly LA; Lehman GA; Sherman S
    Am J Gastroenterol; 2003 May; 98(5):1028-31. PubMed ID: 12809824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pancreatic and biliary tract cancers].
    Sawada T; Yamada N; Hirakawa K
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):865-71. PubMed ID: 11432359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urine diacetylspermine as a novel tumor marker].
    Yamaguchi K; Kaku T; Enjoji M; Kato M; Anai M; Kawakita M; Hamasaki N; Tanaka M
    Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of p53 antibody].
    Shiota G; Kawasaki H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():356-61. PubMed ID: 11761972
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and biliary diseases.
    Laurent-Puig P; Lubin R; Semhoun-Ducloux S; Pelletier G; Fourre C; Ducreux M; Briantais MJ; Buffet C; Soussi T
    Gut; 1995 Mar; 36(3):455-8. PubMed ID: 7698709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA19-9 serum levels in obstructive jaundice: clinical value in benign and malignant conditions.
    Marrelli D; Caruso S; Pedrazzani C; Neri A; Fernandes E; Marini M; Pinto E; Roviello F
    Am J Surg; 2009 Sep; 198(3):333-9. PubMed ID: 19375064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic cytological evaluation and immunocytochemistry of minichromosome maintenance protein 2 and p53 significantly improve cytological diagnosis of pancreaticobiliary adenocarcinoma.
    Abe N; Matsuo K; Kumasaka T; Naka K; Hashimoto S; Takemura T; Fujiwara M; Ito Y; Nakata R; Hashimoto T; Makuuchi M; Soejima Y; Sawabe M
    J Med Dent Sci; 2016; 63(1):19-27. PubMed ID: 27181487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of six serum tumor markers (CEA, CA 50, CA 242, TPA, TPS, TATI) and conventional laboratory tests in the diagnosis of hepatopancreatobiliary malignancy.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1995; 15(6B):2731-7. PubMed ID: 8669855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.
    Müller M; Meyer M; Schilling T; Ulsperger E; Lehnert T; Zentgraf H; Stremmel W; Volkmann M; Galle PR
    Int J Oncol; 2006 Oct; 29(4):973-80. PubMed ID: 16964393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of metallothionein and p53 protein in pancreatic serous cystadenomas.
    Sliwińska-Mossoń M; Milnerowicz H; Rabczyński J; Milnerowicz S
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):295-301. PubMed ID: 19578815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic ultrasound-guided fine-needle aspiration cytology in pancreaticobiliary carcinomas: diagnostic efficacy of cell-block immunocytochemistry.
    Ieni A; Todaro P; Crino SF; Barresi V; Tuccari G
    Hepatobiliary Pancreat Dis Int; 2015 Jun; 14(3):305-12. PubMed ID: 26063033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection.
    Megliorino R; Shi FD; Peng XX; Wang X; Chan EK; Tan EM; Zhang JY
    Cancer Detect Prev; 2005; 29(3):241-8. PubMed ID: 15896923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [IL-6, p53 and proto-oncogene c-myc play different roles as biological markers of plasma cell dyscrasias].
    Alvino S; Marcucci M; Canzoniere D; Mosiello A; Del Monte G; Venturo I; Rinaldi M; Gandolfo GM; Lopez M; Greco C
    Clin Ter; 1999; 150(3):197-202. PubMed ID: 10528431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer.
    Schneider J; Presek P; Braun A; Bauer P; Konietzko N; Wiesner B; Woitowitz HJ
    Br J Cancer; 1999 Aug; 80(12):1987-94. PubMed ID: 10471051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytological diagnosis of neoplasms of the duodenal, hepatic, pancreatic and biliary system].
    Shida S; Matsuzawa Y; Muto K; Takada E
    Rinsho Byori; 1980; Suppl():165-76. PubMed ID: 7411956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.